Drug use Reconsidered in the Elderly using goal Attainment scales during Medication Review - The DREAMeR-study
Completed
- Conditions
- alle aandoeningen waarbij farmacotherapie wordt ingezetn.a.
- Registration Number
- NL-OMON44034
- Lead Sponsor
- SIR Institute for Pharmacy Practice and Policy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 750
Inclusion Criteria
Home-dwelling patients aged 70 years or older, using 7 or more chronic medicines
Exclusion Criteria
Persons receiving repeat prescriptions solely from a specialist. (the GP is not the primary caregiver)
Persons with a life expectancy shorter than 6 months.
Persons who had a hospital admission < 1 month before the start of the trial
Persons who already received a medication review in the past 12 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>1. Health-related quality of life (EQ-5D-5L)<br /><br>2. Number of hindering complaints per patient </p><br>
- Secondary Outcome Measures
Name Time Method <p>1. Health care utilization (used for calculating direct medical costs and<br /><br>non-medical costs)<br /><br>2. The number of drug changes per patient<br /><br>3. The number and type of ceased drugs after 3 and 6 months<br /><br>4. The number and type of added drugs after 3 and 6 months<br /><br>5. The number and type of goals at baseline<br /><br>6. Scores on the Goal Attainment Scales (GAS) measured after 3 and 6 months<br /><br>7. The number and type of drug-related problems (DRPs) per patient<br /><br>8. Implementation rate of the recommendations associated with the DRPs </p><br>